CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 177 enrolled
Drug / intervention
Lyric +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01861704
NCT01861704N/ACompleted

Post-market Study to Capture Information Regarding Performance of Extended Wear Hearing Aid Lyric2 Compared to Lyric

Phonak AG, Switzerland·interventional·Posted May 24, 2013·Updated May 19, 2014

In Brief

A clinical study evaluating Lyric and Lyric2 for Hearing Loss. Completed, enrolled 177 participants across 1 site.

Detailed Summary

Randomized post market study comparing Lyric to Lyric2 capturing information regarding comparative performance and safety.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMay 24, 2013
Enrollment StartApr 1, 2011
Primary CompletionJan 1, 2012
Study CompletionApr 1, 2012
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 13.1 years ago

Interventions

Lyricdevice

Extended wear hearing instrument

Lyric2device

Extended wear hearing instrument